ATEC · Alphatec Holdings, Inc.
$8.67
+7.50% last session
End-of-day data · updated 2026-07-29
Market cap
$1B
Enterprise value
$2B
Trailing P/E
—
Forward P/E
15.8
Dividend yield
—
Beta
0.85
Avg volume
3M
Employees
1K
2D change
7.50%
5D change
12.83%
10D change
9.13%
30D change
-1.89%
60D change
20.26%
MTD change
5.19%
YTD change
-55.70%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — ATEC
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-07-28
Latest call per bank · past 12 months
UBS
Buy$15.00
+73.0% vs priceBarclays
Overweight$24.00
+176.8% vs priceWells Fargo
Overweight$14.00
+61.5% vs priceJP Morgan
Overweight$16.00
+84.5% vs priceMorgan Stanley
Equal-Weight$21.00
+142.2% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-07-28 | UBS | Initiates | Buy | $0.00 → $15.00 |
| 2026-07-23 | Stephens & Co. | Initiates | Overweight | $0.00 → $15.00 |
| 2026-07-09 | BMO Capital | Initiates | Outperform | $0.00 → $11.00 |
| 2026-07-08 | Stifel | Maintains | Buy | $16.00 → $13.00 |
| 2026-05-07 | Barclays | Maintains | Overweight | $27.00 → $24.00 |
| 2026-05-07 | Wells Fargo | Maintains | Overweight | $28.00 → $14.00 |
| 2026-05-07 | HC Wainwright & Co. | Reiterates | Buy | $24.00 |
| 2026-05-06 | Canaccord Genuity | Maintains | Buy | $25.00 → $23.00 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-07-28
- RSI (14): RSI is 58 — neutral momentum, neither overbought nor oversold.
- Price vs 50-day MA: Trading 9.7% above the 50-day MA ($8.50).
- Price vs 200-day MA: Trading 31.6% below the 200-day MA ($13.62).
- MA cross: The 50-day MA sits below the 200-day MA (death-cross regime) — the longer-term trend points down.
- MACD (12,26,9): MACD histogram is negative (-0.03) — short-term momentum is fading.
- 52-week range: Price sits between the 52-week low ($6.99) and high ($22.68).
ATEC Price Chart
Loading chart for ATEC…
Fundamentals
About Alphatec Holdings, Inc.
Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. The company manufactures and sells implants, instruments, imaging equipment, and spare parts. It offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; SafeOp Neural InformatiX System that automates electromyographic, somatosensory evoked potential, and motor evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems. It also provides split-blade retractors; Sigma-ALIF Access System, a procedure-specific access system; spinal implants and fixation systems comprising NanoTec and Invictus, as well as various standalone implants for height restoration and stabilization. In addition, the company provides biologics comprising 3D ProFuse Osteoconductive Bioscaffold; AlphaGRAFT Demineralized Bone Matrix (DBM) comprising demineralized human tissue; BioCORE Moldable Bioactive Graft, a synthetic mineral-collagen composite matrix that can be molded to fit the bone defect; AlphaGRAFT DBM Fibers comprising demineralized fibers; AlphaGRAFT Cellular Bone Matrix (CBM), a growth factor-enriched cellular bone matrix; AlphaGRAFT CBM that is delivered in granular, fiber, or structural form; and Amnioshield Amniotic Tissue Barrier, an allograft for spinal surgical barrier applications. The company sells its products through a network of independent sales agents and direct sales representatives. The company was founded in 1990 and is headquartered in Carlsbad, California.
More in Medical Devices
SYK
Stryker Corporation
$133B -0.9% YTD
BSX
Boston Scientific Corporation
$68B -51.7% YTD
EW
Edwards Lifesciences Corporatio
$48B -1.8% YTD
GEHC
GE HealthCare Technologies Inc.
$29B -21.7% YTD
DXCM
DexCom, Inc.
$29B 12.8% YTD
PHG
Koninklijke Philips N.V. NY Reg
$25B -2.0% YTD
STE
STERIS plc (Ireland)
$22B -8.6% YTD
ZBH
Zimmer Biomet Holdings, Inc.
$19B 7.1% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.